Patents Assigned to Pharmingen
  • E2A/pbx1 fusion protein specific monoclonal antibodies
    Patent number: 5858682
    Abstract: A monoclonal antibody which specifically binds with an E2A/pbx1 fusion epitope.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: January 12, 1999
    Assignee: Pharmingen
    Inventors: Stefan Gruenwald, Bi-Ching Sang, Craig Monell